NCT00567580
Clinical Trial Information
Trial Number: NCT00567580 (ClinicalTrials.gov)
Disease Type:
- Reproductive System Neoplasm, Male - Prostate Cancer
Trial Title:
A PHASE III TRIAL OF SHORT TERM ANDROGEN DEPRIVATION WITH PELVIC LYMPH NODE OR PROSTATE BED ONLY RADIOTHERAPY (SPPORT) IN PROSTATE CANCER PATIENTS WITH A RISING PSA AFTER RADICAL PROSTATECTOMY
Study ID:
RTOG-0534
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT00567580-D4 | This dataset, NCT00567580-D4, contains the late adverse event data presented in the RTOG-0534 primary publication (PMID: 35569466). NCT00567580-D1 contains outcome data. NCT00567580-D2 contains highest-grade adverse events. NCT00567580-D3 contains acute adverse events. |
| NCT00567580-D3 | This dataset, NCT00567580-D3, contains the acute adverse event data presented in the RTOG-0534 primary publication (PMID: 35569466). NCT00567580-D1 contains outcome data. NCT00567580-D2 contains highest-grade adverse events. NCT00567580-D4 contains late adverse events. |
| NCT00567580-D2 | This dataset, NCT00567580-D2, contains the highest-grade adverse event data presented in the RTOG-0534 primary publication (PMID: 35569466). NCT00567580-D1 contains outcome data. NCT00567580-D3 contains acute adverse events. NCT00567580-D4 contains late adverse events. |
| NCT00567580-D1 | NCT00567580-D1: This dataset, NCT00567580-D1, contains the patient characteristics, outcome, and toxicity data presented in the RTOG-0534 primary publication (PMID: 35569466). NCT00567580-D2 contains highest-grade adverse events. NCT00567580-D3 contains acute adverse events. NCT00567580-D4 contains late adverse events. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®